Mayur is finishing his Ph.D in Biomedical Engineering at Columbia University where he cofounded Ardent Cell Technologies, a cell therapeutics company entering clinical trials. Before joining Columbia he worked at Boston Consulting Group designing predictive models and precision medicine product pipelines for healthcare giants like Boston Scientific. He believes that opportunities shaping and contributing towards value based care are the way forward.
So in terms of IP strategy, you can do patents, you can do licensing, you can do trade secrets. Depending on what business you are in, depending on what market you are in, depending on the rate at which you want to move into the market, you choose one. It?s not only about whether it can protect yo...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
